VIRGILE
VIRGILE 是一项为期 3 年的非干预性、观察性研究,设计旨在评估芬戈莫德在法国真实世界条件下接受芬戈莫德治疗的患者 (N=1443) 中的有效性和耐受性,并进行长达 2 年的额外随访
AE 和 SAE 的发生率1


It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.
VIRGILE 是一项为期 3 年的非干预性、观察性研究,设计旨在评估芬戈莫德在法国真实世界条件下接受芬戈莫德治疗的患者 (N=1443) 中的有效性和耐受性,并进行长达 2 年的额外随访
AE 和 SAE 的发生率1
This website is for non-promotional purposes and is intended for providing
safety information for healthcare professionals (HCP) only
Please confirm that you are an HCP
For HCPs: Information on this website is not country specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.
For non-HCPs / patients: This safety website is available for HCPs only